PRNewswire/ - Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and commercialization of ...

The Specifications were jointly developed by the Expert Committee of the National Health Commission on Antimicrobial Susceptibility Testing and Standard Research (hereinafter referred to as the ...

Get Instant Summarized Text (Gist) Infuzide, a newly synthesized hydrazone-containing compound, demonstrates potent activity against multidrug-resistant Gram-positive bacteria, including ...

SHANGHAI & CAMBRIDGE, Mass., June 02, 2025--Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that updated data from an ongoing, global Phase 1a/1b clinical trial (NCT06179069) evaluating ...

Zai Lab Presents Positive Phase 1 Data for ZL-1310, a DLL3-Targeted ADC, Demonstrating Robust Anti-Tumor Activity and Safety in Patients with Extensive-Stage Small Cell Lung Cancer at 2025 ASCO ...

Advocacy for alternatives to animal testing in clinical research is pushing the industry away from animal-based endotoxin ...

("gpt") gold ("Au") over 13.9 metres ("m"), including 42.2 gpt Au over 8.0 m in drill hole HDGC-25-272 53.9 gpt Au over 3.5 m in channel sample HDFN-CH-25-03 and 31.2 gpt Au over 3.2 m in channel ...

The test is the last of three multiplex bloodstream infection panels that the firm has designed for its Liaison Plex molecular testing instrument.